FDA Drug Application (022185) for TACLONEX by LEO PHARMA AS

Back to FDA Applications sponsored by LEO PHARMA AS

Application Number022185
Product Number001
FormSUSPENSION;TOPICAL
Dosage0.064%;0.005%
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameTACLONEX
Active IngredientBETAMETHASONE DIPROPIONATE; CALCIPOTRIENE HYDRATE

Active IngredientCount
List of drugs with Active Ingredient BETAMETHASONE DIPROPIONATE11
List of drugs with Active Ingredient CALCIPOTRIENE HYDRATE2


Back to FDA Applications sponsored by LEO PHARMA AS